|
| Midazolam group (N = 50) | Control group (N = 50) | P-value | |
Eclampsia |
| ||||
Yes | 9 (18%) | 17 (34%) | 0.005* | ||
1 seizure | 2 (4%) | 3 (6%) | |||
2 seizures | 4 (8%) | 12 (24%) | |||
3 seizures | 3 (6%) | 2 (4%) | |||
PRESS | |||||
Yes | 8 (16%) | 22 (44%) | 0.004* | ||
Intracranial hemorrhage | |||||
Yes | 0 (0%) | 1 (2%) | 0.315 | ||
Acute renal failure | |||||
Yes | 0 (0%) | 1 (2%) | 0.315 | ||
Acute renal injury | |||||
Yes | 0 (0%) | 1 (2%) | 0.315 | ||
Liver cell | |||||
Failure | YES | 0 (0%) | 1 (2%) | 0.315 | |
Pulmonary edema | |||||
Yes | 1 (2%) | 2 (4%) | 0.559 |